Lates News
According to AI Fast News, China Galaxy released a research report on August 31, giving a recommended rating to Shanghai Pharmaceuticals (601607.SH). The rating reasons mainly include: 1) stable growth in the commercial sector, with incremental contributions from emerging businesses; 2) performance recovery in the industrial sector, with continuous promotion of innovation and research and development. (Daily Economic News)
Latest